Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03382457 · ClinicalTrials.gov registry record · NA
Clinical Study of Edwards Cardioband FIT Valve Repair System
A NA study of Tricuspid Regurgitation, sponsored by Edwards Lifesciences.
- Active
- Registry status
- NA
- Development phase
- 75
- Enrollment target
- 9
- Study locations
NCT03382457 is a NA study of Tricuspid Regurgitation that is active but no longer recruiting, run by Edwards Lifesciences. The registered enrollment target is 75 participants, below the 531-participant average among 17 other Tricuspid Regurgitation trials with a reported enrollment target (86% lower). The trial reports 9 study locations across 9 states.
The verdict
NCT03382457, a NA study of Tricuspid Regurgitation, is active but no longer recruiting, sponsored by Edwards Lifesciences.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
- 9
- Study locations
Study Summary
Clinical Study of the Edwards Cardioband FIT Repair System
Conditions Studied
Interventions
- DEVICE Transcatheter Tricuspid Valve Repair
Study Locations (9)
Illinois
- Northwestern University - Chicago
Minnesota
- Mayo Clinic - Rochester
New Jersey
- Morristown Medical Center - Morristown
New York
- Columbia University Medical Center /New York Presbyterian Hospital - New York
Oregon
- Oregon Health & Science University - Portland
Pennsylvania
- Lankenau Medical Center - Wynnewood
Texas
- Heart Hospital Baylor Plano - Plano
Utah
- Intermountain Medical Center - Murray
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2018-07-01 |
| Est. Completion | 2031-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03382457
The ClinicalTrials.gov registry entry for NCT03382457 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 531-participant average among 17 other Tricuspid Regurgitation trials with a reported enrollment target (86% lower). The listed sponsor is Edwards Lifesciences, which has 57 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Tricuspid Regurgitation appearing as the primary indexed condition, and to 1 intervention - of which Transcatheter Tricuspid Valve Repair is the first listed.
NCT03382457 reports 9 study locations spanning 9 distinct geographic areas - top geographies include Illinois, Minnesota, New Jersey.
Frequently Asked Questions
What is clinical trial NCT03382457 about?
NCT03382457 is a clinical study titled "Clinical Study of Edwards Cardioband FIT Valve Repair System". Clinical Study of the Edwards Cardioband FIT Repair System
What is the current status of trial NCT03382457?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 75 participants. The study started on 2018-07-01. Estimated completion is 2031-12-31.
What conditions does trial NCT03382457 study?
This clinical trial studies the following conditions: Tricuspid Regurgitation.
What interventions are being tested in trial NCT03382457?
The interventions under investigation include: Transcatheter Tricuspid Valve Repair (DEVICE).
Who is sponsoring clinical trial NCT03382457?
This trial is sponsored by Edwards Lifesciences, which has 57 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03382457 being conducted?
This trial has 9 study locations across Illinois, Minnesota, New Jersey, New York, Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tricuspid Regurgitation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
TTVR Early Feasibility Study
RECRUITING · NA
-
Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation ( VISTA-US)
RECRUITING · NA
-
Early Feasibility Study (EFS) Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System
RECRUITING · NA
-
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
RECRUITING · NA
-
Trisol System EFS Study
RECRUITING · NA
-
EFS of the DUO System for Tricuspid Regurgitation
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.